STOCK TITAN

[8-K] Ethan Allen Interiors Inc Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Medtronic plc (MDT) – Form 4 insider filing. On 07/28/2025 the company granted equity awards to Harry Skip Kiil, EVP & President Cardiovascular. The filing shows no open-market trades; all transactions carry code “A” (award).

  • Restricted Stock Units: 7,612 ordinary shares, vest 100% on the third anniversary. Beneficial ownership of ordinary shares rises to 41,318.
  • Performance Share Units (PSUs): Target 19,028 shares (0–38,056 range) contingent on 3-year performance metrics concluding 04/28/2028.
  • Stock Options: 53,671 options with a $91.97 strike, expiring 07/28/2035; 25% become exercisable each year starting 07/28/2026.

After the grants the insider directly holds 41,318 ordinary shares plus 19,028 PSUs and 53,671 options. The awards represent standard annual long-term incentive compensation meant to align management with shareholders and encourage retention. Given MDT’s ~1.3 bn share count, the dilution impact is immaterial (<0.01%). No sales were reported, so trading sentiment cannot be inferred.

Medtronic plc (MDT) – Comunicazione interna Form 4. Il 28/07/2025 la società ha assegnato premi azionari a Harry Skip Kiil, EVP e Presidente Cardiovascolare. La comunicazione non mostra operazioni sul mercato aperto; tutte le transazioni sono contrassegnate dal codice “A” (assegnazione).

  • Unità di Azioni Vincolate: 7.612 azioni ordinarie, con maturazione del 100% al terzo anniversario. La proprietà effettiva sale a 41.318 azioni ordinarie.
  • Unità di Azioni a Prestazione (PSU): Obiettivo di 19.028 azioni (intervallo 0–38.056) condizionato a metriche di performance triennali con scadenza il 28/04/2028.
  • Opzioni su Azioni: 53.671 opzioni con prezzo di esercizio di $91,97, con scadenza il 28/07/2035; il 25% diventa esercitabile ogni anno a partire dal 28/07/2026.

Dopo queste assegnazioni, l’insider detiene direttamente 41.318 azioni ordinarie, oltre a 19.028 PSU e 53.671 opzioni. I premi rappresentano una compensazione annuale standard a lungo termine, finalizzata ad allineare la gestione con gli azionisti e favorire la retention. Considerando il numero di azioni MDT (~1,3 miliardi), l’impatto diluitivo è irrilevante (<0,01%). Non sono state segnalate vendite, quindi non è possibile dedurre il sentiment di mercato.

Medtronic plc (MDT) – Declaración interna Formulario 4. El 28/07/2025 la compañía otorgó premios accionarios a Harry Skip Kiil, EVP y Presidente de Cardiovascular. La declaración no muestra operaciones en mercado abierto; todas las transacciones llevan el código “A” (adjudicación).

  • Unidades de Acciones Restringidas: 7,612 acciones ordinarias, que se consolidan al 100% en el tercer aniversario. La propiedad beneficiaria de acciones ordinarias aumenta a 41,318.
  • Unidades de Acciones por Desempeño (PSU): Objetivo de 19,028 acciones (rango 0–38,056) condicionado a métricas de desempeño a 3 años que concluyen el 28/04/2028.
  • Opciones sobre Acciones: 53,671 opciones con precio de ejercicio de $91.97, expiran el 28/07/2035; el 25% se vuelve ejercitable cada año a partir del 28/07/2026.

Tras las adjudicaciones, el insider posee directamente 41,318 acciones ordinarias más 19,028 PSU y 53,671 opciones. Los premios representan una compensación anual estándar a largo plazo destinada a alinear la gestión con los accionistas y fomentar la retención. Dado el número aproximado de acciones de MDT (~1.3 mil millones), el impacto dilutivo es insignificante (<0.01%). No se reportaron ventas, por lo que no se puede inferir el sentimiento de trading.

Medtronic plc (MDT) – 내부자 거래 신고서 Form 4. 2025년 7월 28일, 회사는 EVP 겸 심혈관 부문 사장인 Harry Skip Kiil에게 주식 보상을 부여했습니다. 신고서에는 시장 내 거래 없음이 명시되어 있으며, 모든 거래는 코드 “A”(수여)로 표시되어 있습니다.

  • 제한 주식 단위: 7,612 보통주, 3년 후 100% 완전 취득. 보유 주식 수는 41,318주로 증가합니다.
  • 성과 주식 단위(PSU): 목표 19,028주 (0~38,056 범위), 3년 성과 지표에 따라 2028년 4월 28일에 최종 확정.
  • 스톡 옵션: 행사 가격 $91.97, 만기 2035년 7월 28일, 53,671주; 2026년 7월 28일부터 매년 25%씩 행사 가능.

이번 부여 후 내부자는 직접 41,318 보통주와 19,028 PSU, 53,671 옵션을 보유하게 됩니다. 이 보상은 경영진과 주주 간 이해관계 일치를 유도하고 인재 유지를 장려하기 위한 표준 연간 장기 인센티브입니다. MDT의 약 13억 주 발행 주식 수를 고려할 때 희석 효과는 미미하며(<0.01%), 매도 보고가 없어 거래 심리는 파악할 수 없습니다.

Medtronic plc (MDT) – Déclaration d’initié Formulaire 4. Le 28/07/2025, la société a attribué des actions à Harry Skip Kiil, EVP et Président Cardiovasculaire. La déclaration ne montre aucune transaction sur le marché ouvert ; toutes les transactions portent le code « A » (attribution).

  • Unités d’actions restreintes : 7 612 actions ordinaires, acquises à 100 % au troisième anniversaire. La propriété bénéficiaire d’actions ordinaires passe à 41 318.
  • Unités d’actions de performance (PSU) : Objectif de 19 028 actions (plage 0–38 056), conditionné à des indicateurs de performance sur 3 ans se terminant le 28/04/2028.
  • Options d’achat d’actions : 53 671 options avec un prix d’exercice de 91,97 $, expirant le 28/07/2035 ; 25 % deviennent exerçables chaque année à partir du 28/07/2026.

Après ces attributions, l’initié détient directement 41 318 actions ordinaires ainsi que 19 028 PSU et 53 671 options. Ces attributions représentent une rémunération annuelle standard à long terme visant à aligner la direction avec les actionnaires et à encourager la fidélisation. Étant donné le nombre d’actions MDT (~1,3 milliard), l’impact dilutif est négligeable (<0,01 %). Aucune vente n’a été signalée, il n’est donc pas possible d’inférer le sentiment du marché.

Medtronic plc (MDT) – Insider-Meldung Form 4. Am 28.07.2025 hat das Unternehmen Aktienzuteilungen an Harry Skip Kiil, EVP & Präsident Cardiovascular, vorgenommen. Die Meldung zeigt keine Transaktionen am offenen Markt; alle Vorgänge sind mit dem Code „A“ (Zuteilung) gekennzeichnet.

  • Restricted Stock Units: 7.612 Stammaktien, die zu 100 % am dritten Jahrestag freigegeben werden. Das wirtschaftliche Eigentum an Stammaktien steigt auf 41.318.
  • Performance Share Units (PSUs): Zielwert 19.028 Aktien (Spanne 0–38.056), abhängig von 3-Jahres-Leistungskennzahlen mit Abschluss am 28.04.2028.
  • Aktienoptionen: 53.671 Optionen mit einem Ausübungspreis von 91,97 $, Laufzeit bis 28.07.2035; 25 % werden jährlich ab dem 28.07.2026 ausübbar.

Nach den Zuteilungen hält der Insider direkt 41.318 Stammaktien sowie 19.028 PSUs und 53.671 Optionen. Die Zuwendungen stellen eine standardmäßige jährliche langfristige Vergütung dar, die darauf abzielt, das Management mit den Aktionären in Einklang zu bringen und die Bindung zu fördern. Angesichts der rund 1,3 Mrd. Aktien von MDT ist die Verwässerung gering (<0,01 %). Es wurden keine Verkäufe gemeldet, daher lässt sich keine Handelstendenz ableiten.

Positive
  • Alignment of interests: Performance-based and time-vested awards encourage long-term value creation.
  • No insider selling: Entire transaction consists of equity grants; no negative sell signal.
Negative
  • Potential dilution: If all awards vest/exercise, 80,311 new shares could be issued, albeit immaterial relative to total shares.

Insights

TL;DR: Routine equity grant to MDT senior executive; negligible dilution and neutral fundamental impact.

The Form 4 discloses routine long-term incentive awards—RSUs, PSUs and options—to EVP Harry Kiil. The option strike of $91.97 matches the market on grant date, so value creation depends on future price appreciation. PSUs add performance conditions, tying payout to company metrics through 2028. The total shares involved (< 0.07 % of equity) are too small to alter valuation or float dynamics. With no dispositions, the filing neither signals insider confidence nor concern. I classify the filing as neutral/not impactful for investors.

Medtronic plc (MDT) – Comunicazione interna Form 4. Il 28/07/2025 la società ha assegnato premi azionari a Harry Skip Kiil, EVP e Presidente Cardiovascolare. La comunicazione non mostra operazioni sul mercato aperto; tutte le transazioni sono contrassegnate dal codice “A” (assegnazione).

  • Unità di Azioni Vincolate: 7.612 azioni ordinarie, con maturazione del 100% al terzo anniversario. La proprietà effettiva sale a 41.318 azioni ordinarie.
  • Unità di Azioni a Prestazione (PSU): Obiettivo di 19.028 azioni (intervallo 0–38.056) condizionato a metriche di performance triennali con scadenza il 28/04/2028.
  • Opzioni su Azioni: 53.671 opzioni con prezzo di esercizio di $91,97, con scadenza il 28/07/2035; il 25% diventa esercitabile ogni anno a partire dal 28/07/2026.

Dopo queste assegnazioni, l’insider detiene direttamente 41.318 azioni ordinarie, oltre a 19.028 PSU e 53.671 opzioni. I premi rappresentano una compensazione annuale standard a lungo termine, finalizzata ad allineare la gestione con gli azionisti e favorire la retention. Considerando il numero di azioni MDT (~1,3 miliardi), l’impatto diluitivo è irrilevante (<0,01%). Non sono state segnalate vendite, quindi non è possibile dedurre il sentiment di mercato.

Medtronic plc (MDT) – Declaración interna Formulario 4. El 28/07/2025 la compañía otorgó premios accionarios a Harry Skip Kiil, EVP y Presidente de Cardiovascular. La declaración no muestra operaciones en mercado abierto; todas las transacciones llevan el código “A” (adjudicación).

  • Unidades de Acciones Restringidas: 7,612 acciones ordinarias, que se consolidan al 100% en el tercer aniversario. La propiedad beneficiaria de acciones ordinarias aumenta a 41,318.
  • Unidades de Acciones por Desempeño (PSU): Objetivo de 19,028 acciones (rango 0–38,056) condicionado a métricas de desempeño a 3 años que concluyen el 28/04/2028.
  • Opciones sobre Acciones: 53,671 opciones con precio de ejercicio de $91.97, expiran el 28/07/2035; el 25% se vuelve ejercitable cada año a partir del 28/07/2026.

Tras las adjudicaciones, el insider posee directamente 41,318 acciones ordinarias más 19,028 PSU y 53,671 opciones. Los premios representan una compensación anual estándar a largo plazo destinada a alinear la gestión con los accionistas y fomentar la retención. Dado el número aproximado de acciones de MDT (~1.3 mil millones), el impacto dilutivo es insignificante (<0.01%). No se reportaron ventas, por lo que no se puede inferir el sentimiento de trading.

Medtronic plc (MDT) – 내부자 거래 신고서 Form 4. 2025년 7월 28일, 회사는 EVP 겸 심혈관 부문 사장인 Harry Skip Kiil에게 주식 보상을 부여했습니다. 신고서에는 시장 내 거래 없음이 명시되어 있으며, 모든 거래는 코드 “A”(수여)로 표시되어 있습니다.

  • 제한 주식 단위: 7,612 보통주, 3년 후 100% 완전 취득. 보유 주식 수는 41,318주로 증가합니다.
  • 성과 주식 단위(PSU): 목표 19,028주 (0~38,056 범위), 3년 성과 지표에 따라 2028년 4월 28일에 최종 확정.
  • 스톡 옵션: 행사 가격 $91.97, 만기 2035년 7월 28일, 53,671주; 2026년 7월 28일부터 매년 25%씩 행사 가능.

이번 부여 후 내부자는 직접 41,318 보통주와 19,028 PSU, 53,671 옵션을 보유하게 됩니다. 이 보상은 경영진과 주주 간 이해관계 일치를 유도하고 인재 유지를 장려하기 위한 표준 연간 장기 인센티브입니다. MDT의 약 13억 주 발행 주식 수를 고려할 때 희석 효과는 미미하며(<0.01%), 매도 보고가 없어 거래 심리는 파악할 수 없습니다.

Medtronic plc (MDT) – Déclaration d’initié Formulaire 4. Le 28/07/2025, la société a attribué des actions à Harry Skip Kiil, EVP et Président Cardiovasculaire. La déclaration ne montre aucune transaction sur le marché ouvert ; toutes les transactions portent le code « A » (attribution).

  • Unités d’actions restreintes : 7 612 actions ordinaires, acquises à 100 % au troisième anniversaire. La propriété bénéficiaire d’actions ordinaires passe à 41 318.
  • Unités d’actions de performance (PSU) : Objectif de 19 028 actions (plage 0–38 056), conditionné à des indicateurs de performance sur 3 ans se terminant le 28/04/2028.
  • Options d’achat d’actions : 53 671 options avec un prix d’exercice de 91,97 $, expirant le 28/07/2035 ; 25 % deviennent exerçables chaque année à partir du 28/07/2026.

Après ces attributions, l’initié détient directement 41 318 actions ordinaires ainsi que 19 028 PSU et 53 671 options. Ces attributions représentent une rémunération annuelle standard à long terme visant à aligner la direction avec les actionnaires et à encourager la fidélisation. Étant donné le nombre d’actions MDT (~1,3 milliard), l’impact dilutif est négligeable (<0,01 %). Aucune vente n’a été signalée, il n’est donc pas possible d’inférer le sentiment du marché.

Medtronic plc (MDT) – Insider-Meldung Form 4. Am 28.07.2025 hat das Unternehmen Aktienzuteilungen an Harry Skip Kiil, EVP & Präsident Cardiovascular, vorgenommen. Die Meldung zeigt keine Transaktionen am offenen Markt; alle Vorgänge sind mit dem Code „A“ (Zuteilung) gekennzeichnet.

  • Restricted Stock Units: 7.612 Stammaktien, die zu 100 % am dritten Jahrestag freigegeben werden. Das wirtschaftliche Eigentum an Stammaktien steigt auf 41.318.
  • Performance Share Units (PSUs): Zielwert 19.028 Aktien (Spanne 0–38.056), abhängig von 3-Jahres-Leistungskennzahlen mit Abschluss am 28.04.2028.
  • Aktienoptionen: 53.671 Optionen mit einem Ausübungspreis von 91,97 $, Laufzeit bis 28.07.2035; 25 % werden jährlich ab dem 28.07.2026 ausübbar.

Nach den Zuteilungen hält der Insider direkt 41.318 Stammaktien sowie 19.028 PSUs und 53.671 Optionen. Die Zuwendungen stellen eine standardmäßige jährliche langfristige Vergütung dar, die darauf abzielt, das Management mit den Aktionären in Einklang zu bringen und die Bindung zu fördern. Angesichts der rund 1,3 Mrd. Aktien von MDT ist die Verwässerung gering (<0,01 %). Es wurden keine Verkäufe gemeldet, daher lässt sich keine Handelstendenz ableiten.

false 0000896156 0000896156 2025-07-30 2025-07-30
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 30, 2025
 
ETHAN ALLEN INTERIORS INC.
 
(Exact name of registrant as specified in its charter)
 
Delaware
1-11692
06-1275288
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
25 Lake Avenue Ext., Danbury, Connecticut
06811-5286
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code: (203) 743-8000
 
Former name or former address, if changed since last report: None
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 Par Value
ETD
New York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company         
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


 
 

 
Item 2.02         Results of Operations and Financial Condition
 
On July 30, 2025, Ethan Allen Interiors Inc. (“Ethan Allen” or the “Company”) issued a press release announcing its financial results for the fiscal 2025 full year and fourth quarter ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein. The information furnished pursuant to this Item 2.02 (Results of Operations and Financial Condition), including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (such act being the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
 
Exhibit 99.1 to this Current Report contains certain financial measures that are considered non-GAAP financial measures as defined in the rules issued by the Securities and Exchange Commission. Exhibit 99.1 to this Current Report also contains the reconciliation of these non-GAAP financial measures to their most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles, as well as the reasons why the Company’s management believes that presentation of the non-GAAP financial measures provides useful information to investors regarding Ethan Allen’s results of operations and, to the extent material, a statement disclosing any other additional purposes for which the Company’s management uses the non-GAAP financial measures.
 
Item 9.01         Financial Statements and Exhibits
 
(d) Exhibits
 
Exhibit No.
Description
99.1
Press release dated July 30, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ETHAN ALLEN INTERIORS INC.
(Registrant)
   
Date: July 30, 2025
By:
/s/ Matthew J. McNulty
   
Matthew J. McNulty
Senior Vice President, Chief Financial Officer and Treasurer
(Principal Financial Officer)
 
 

FAQ

What did Medtronic (MDT) disclose in the latest Form 4?

The company granted RSUs, PSUs and stock options to EVP Harry Kiil on 07/28/2025; no shares were sold.

How many Medtronic shares were granted to the executive?

7,612 RSUs, 19,028 target PSUs (up to 38,056), and 53,671 stock options.

What is the strike price and term of the new stock options?

Options have a $91.97 strike price and expire on 07/28/2035.

When will the restricted stock units vest?

All RSUs vest on the third anniversary of the grant date—07/28/2028.

Is this insider transaction material to Medtronic investors?

No; the total potential dilution is less than 0.01 % of outstanding shares, making the impact immaterial.
Ethan Allen Interiors Inc

NYSE:ETD

ETD Rankings

ETD Latest News

ETD Latest SEC Filings

ETD Stock Data

742.30M
22.94M
9.95%
88.38%
12.04%
Furnishings, Fixtures & Appliances
Wood Household Furniture, (no Upholstered)
Link
United States
DANBURY